Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL1640555

Cc1c(Cl)cccc1Cl.N

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
CYP1A2 P05177 3/20 0.47
CYP2A6 P11509 2/20 0.47
TSHR P16473 3/20 0.47
LMNA P02545 3/20 0.47
CYP3A4 P08684 2/20 0.45
PIK3CA P42336 1/20 0.45
MAPT P10636 2/20 0.43
RAPGEF4 Q8WZA2 1/20 0.43
POLB P06746 1/20 0.42
IDO1 P14902 1/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RECQL P46063 1/20 0.39
USP2 O75604 1/20 0.39
MT-CO2 P00403 1/20 0.39
TTR P02766 1/20 0.39
PLA2G1B P04054 1/20 0.39
PGR P06401 1/20 0.39
HTR1A P08908 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112040 0.97
Fluoride SCHEMBL28877073 0.93 ALDH1A1 (0.62) ALDH1A1CYP1A2CYP2A6TSHRLMNA
Hydrochloric Acid SCHEMBL10426264 0.93 ALDH1A1 (0.62) ALDH1A1CYP1A2CYP2A6TSHRLMNA
Chloroform SCHEMBL9943936 0.88 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2A6TSHRLMNA
Ammonia Solution, Strong SCHEMBL11025387 0.85 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2A6TSHRLMNA
SCHEMBL11762263 0.83 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP2A6TSHRLMNA
SCHEMBL251582 0.81
Formaldoxime SCHEMBL29083081 0.81 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2A6TSHRLMNA
Ammonia Solution, Strong SCHEMBL4154603 0.81 ALDH1A1 (0.95) ALDH1A1CYP1A2CYP2A6TSHRLMNA
Ammonia Solution, Strong SCHEMBL28157846 0.81 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2A6TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098324-A1 PROLYL HYDROXYLASE INHIBITORS GLAXOSMITHKLINE LLC 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098324-A1 PROLYL HYDROXYLASE INHIBITORS HIF1AN, EGLN2, EGLN3 ALDH1A1 227/4885CYP1A2 361/4885CYP2A6 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.